CVS Health ROE 2010-2024 | CVS

Current and historical return on equity (ROE) values for CVS Health (CVS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
CVS Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $4.61B $75.73B 6.15%
2024-09-30 $5.02B $75.11B 6.67%
2024-06-30 $7.19B $75.11B 9.57%
2024-03-31 $7.32B $74.15B 9.82%
2023-12-31 $8.34B $76.64B 11.29%
2023-09-30 $8.63B $74.51B 11.87%
2023-06-30 $2.97B $73.00B 4.13%
2023-03-31 $4.09B $71.58B 5.65%
2022-12-31 $4.31B $71.77B 5.90%
2022-09-30 $3.37B $71.01B 4.56%
2022-06-30 $8.38B $75.51B 11.18%
2022-03-31 $8.13B $74.14B 10.93%
2021-12-31 $8.00B $75.38B 10.86%
2021-09-30 $7.58B $74.62B 10.49%
2021-06-30 $7.20B $73.57B 10.16%
2021-03-31 $7.40B $71.16B 10.63%
2020-12-31 $7.18B $69.70B 10.53%
2020-09-30 $7.95B $69.11B 11.91%
2020-06-30 $8.26B $68.36B 12.66%
2020-03-31 $7.22B $65.47B 11.36%
2019-12-31 $6.63B $64.17B 10.67%
2019-09-30 $4.47B $62.93B 7.35%
2019-06-30 $4.33B $61.60B 7.99%
2019-03-31 $-0.17B $60.01B -0.36%
2018-12-31 $-0.59B $58.54B -1.40%
2018-09-30 $3.11B $36.62B 8.38%
2018-06-30 $3.01B $35.61B 8.19%
2018-03-31 $6.67B $38.68B 18.35%
2017-12-31 $6.62B $37.70B 18.85%
2017-09-30 $5.04B $34.87B 14.44%
2017-06-30 $5.30B $34.15B 15.05%
2017-03-31 $5.12B $33.84B 14.49%
2016-12-31 $5.32B $36.83B 14.81%
2016-09-30 $5.11B $35.95B 14.19%
2016-06-30 $4.81B $34.77B 13.26%
2016-03-31 $5.16B $36.03B 13.99%
2015-12-31 $5.24B $37.20B 14.11%
2015-09-30 $5.06B $37.18B 13.56%
2015-06-30 $4.76B $37.13B 12.68%
2015-03-31 $4.74B $37.00B 12.53%
2014-12-31 $4.64B $37.96B 12.19%
2014-09-30 $4.59B $38.11B 12.04%
2014-06-30 $4.89B $38.13B 12.80%
2014-03-31 $4.77B $38.21B 12.41%
2013-12-31 $4.59B $37.94B 11.96%
2013-09-30 $4.44B $38.53B 11.59%
2013-06-30 $4.20B $38.91B 11.08%
2013-03-31 $4.04B $38.21B 10.73%
2012-12-31 $3.86B $37.65B 10.27%
2012-09-30 $3.81B $36.92B 10.11%
2012-06-30 $3.68B $37.91B 9.70%
2012-03-31 $3.53B $38.05B 9.29%
2011-12-31 $3.46B $38.05B 9.13%
2011-09-30 $3.42B $37.49B 9.05%
2011-06-30 $3.36B $38.24B 8.94%
2011-03-31 $3.37B $37.92B 9.10%
2010-12-31 $3.43B $37.70B 9.40%
2010-09-30 $3.45B $36.64B 9.59%
2010-06-30 $3.66B $35.87B 10.25%
2010-03-31 $3.73B $35.69B 10.41%
2009-12-31 $3.70B $35.77B 10.35%
Sector Industry Market Cap Revenue
Medical Medical Services $84.839B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.529B 24.94
Elevance Health (ELV) United States $96.108B 12.88
Cencora (COR) United States $55.604B 20.18
DiDi Global (DIDIY) China $20.317B 29.86
Natera (NTRA) United States $20.018B 0.00
BioMerieux (BMXMF) France $15.594B 0.00
Solventum (SOLV) United States $11.463B 10.69
ICON (ICLR) Ireland $11.251B 10.22
EUROFINS SCIENT (ERFSF) Luxembourg $11.063B 0.00
Revvity (RVTY) United States $11.032B 18.74
CochLear (CHEOY) Australia $10.876B 0.00
Avantor (AVTR) United States $10.289B 15.10
Doximity (DOCS) United States $9.934B 51.66
Viatris (VTRS) United States $9.024B 2.85
Medpace Holdings (MEDP) United States $8.956B 23.46
Sonic Healthcare (SKHHY) Australia $7.706B 0.00
HealthEquity (HQY) United States $7.311B 35.97
Charles River Laboratories (CRL) United States $5.209B 10.28
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.262B 19.45
Alignment Healthcare (ALHC) United States $3.499B 0.00
Sotera Health (SHC) United States $2.975B 17.18
BrightSpring Health Services (BTSG) United States $2.905B 30.18
Organon (OGN) United States $2.868B 2.92
Surgery Partners (SGRY) United States $2.708B 31.21
GeneDx Holdings (WGS) United States $2.680B 318.23
Concentras Parent (CON) United States $2.613B 13.59
Progyny (PGNY) United States $1.837B 40.45
Ardent Health Partners (ARDT) United States $1.786B 0.00
Premier (PINC) United States $1.765B 11.30
GoodRx Holdings (GDRX) United States $1.720B 37.38
Agilon Health (AGL) United States $1.649B 0.00
PACS (PACS) United States $1.411B 0.00
Teladoc Health (TDOC) United States $1.197B 0.00
Pediatrix Medical (MD) United States $1.100B 9.22
Ryman Healthcare (RYHTY) New Zealand $1.035B 0.00
CareDx (CDNA) United States $0.977B 16.62
Establishment Labs Holdings (ESTA) $0.907B 0.00
Nutex Health (NUTX) United States $0.824B 16.14
AMN Healthcare Services Inc (AMN) United States $0.706B 5.59
Embecta (EMBC) United States $0.659B 4.52
Auna S.A (AUNA) Luxembourg $0.515B 13.65
QDM (QDMI) Hong Kong, SAR China $0.496B 0.00
SBC Medicals (SBC) United States $0.417B 0.00
Sonida Senior Living (SNDA) United States $0.405B 0.00
Enhabit (EHAB) United States $0.388B 36.57
InnovAge Holding (INNV) United States $0.372B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.290B 0.00
LifeMD (LFMD) United States $0.242B 0.00
DocGo (DCGO) United States $0.216B 8.83
Performant Healthcare (PHLT) United States $0.195B 0.00
Oncology Institute (TOI) United States $0.163B 0.00
Sera Prognostics (SERA) United States $0.128B 0.00
Beauty Health (SKIN) United States $0.106B 0.00
So-Young (SY) China $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.082B 0.00
OncoCyte (OCX) United States $0.081B 0.00
Biodesix (BDSX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.018B 0.00
ModivCare (MODV) United States $0.014B 4.93
Co-Diagnostics (CODX) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Aclarion (ACON) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00